علاج مريء باريت مع خلل التنسج عالي الدرجة المؤكد أو السرطان داخل الغشاء المخاطي

References

DOI: 10.14309/ajg.0000000000001680

• We recommend EET compared with esophagectomy in patients with BE with HGD or IMC (strength of recommendation: strong; quality of evidence: moderate).
• We suggest initial ER of any visible lesions before the application of ablative therapy in patients with BE undergoing EET (strength of recommendation: conditional; quality of evidence: very low).
• Priority quality indicators established include monitoring the rate at which CEIM is achieved by 18 months in patients with BE-related dysplasia and IMC referred for EET (outcome measure, threshold 70%), and the rate at which CED is achieved by 18 months in patients with BE-related dysplasia and IMC referred for EET (outcome measure, threshold 80%).